Literature DB >> 31961262

Risk of Acute Kidney Injury Following Contrast-enhanced CT in Hospitalized Pediatric Patients: A Propensity Score Analysis.

Leah A Gilligan1, Matthew S Davenport1, Andrew T Trout1, Weizhe Su1, Bin Zhang1, Stuart L Goldstein1, Jonathan R Dillman1.   

Abstract

Background Acute kidney injury (AKI) remains a concern in hospitalized children undergoing CT with intravenous iodinated contrast material (ICM). Adult studies have shown frequencies of AKI after CT with intravenous ICM to be similar to propensity score-matched ICM-unexposed patient groups; similar data in pediatric patients are lacking. Purpose To evaluate the association between intravenous ICM exposure and AKI in hospitalized pediatric patients with stable kidney function undergoing contrast material-enhanced CT by comparing with a propensity score-matched ICM-unexposed patient sample undergoing abdominal US. Materials and Methods In this retrospective observational study, hospitalized patients aged 18 years or younger with stable kidney function and available serum creatinine (SCr) measurement before and after imaging who underwent CT with intravenous ICM or abdominal US (control group) between January 2009 and November 2018 were identified. The 1:1 propensity score matching was performed by using 23 covariates, stratified by estimated glomerular filtration rate (eGFR) before imaging (≥60 mL/min/1.73 m2 or <60 mL/min/1.73 m2). AKI was defined by using Acute Kidney Injury Network SCr-related criteria. Multivariable logistic regression was performed to identify risk factors for AKI after imaging, including the effects of eGFR and intravenous ICM exposure before imaging. Results A total of 1850 unique patients were included in the propensity score-matched sample (925 exposed to ICM [mean age ± standard deviation, 8 years ± 6; 484 female patients]; 925 unexposed to ICM [mean age, 7 years ± 6; 484 female patients]). Frequency of AKI with eGFR greater than or equal to 60 mL/min/1.73 m2 was 2.2% (20 of 889) for CT and US (odds ratio [OR]: 0.98; 95% confidence interval [CI]: 0.52, 1.86; adjusted P = .95) and with eGFR less than 60 mL/min/1.73 m2 was 5.6% (two of 36) and 11.1% (four of 36) for CT and US, respectively (OR: 0.75; 95% CI: 0.11, 5.00; adjusted P = .76). Significant multivariable predictors of AKI included eGFR before imaging (OR: 0.99; 95% CI: 0.98, 0.995; P = .001), body mass index (OR: 1.06; 95% CI: 1.02, 1.10; P = .003), acquired kidney disease (OR: 1.95; 95% CI: 1.004, 3.78; P = .049), and nephrotoxic antibiotic exposure (OR: 2.86; 95% CI: 1.55, 5.25; P < .001). Intravenous ICM exposure was not predictive (OR: 0.91; 95% CI: 0.51, 1.64; P > .05). Conclusion Hospitalized children with stable kidney function who underwent CT with intravenous iodinated contrast material (ICM) had a similar frequency of acute kidney injury (AKI) compared with a propensity score-matched ICM-unexposed patient group. In pediatric inpatients with estimated glomerular filtration rate greater than or equal to 60 mL/min/1.73 m2, ICM was not independently associated with AKI. © RSNA, 2020 Online supplemental material is available for this article. See also the editorial by Paltiel in this issue.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31961262      PMCID: PMC7053230          DOI: 10.1148/radiol.2020191931

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  19 in total

1.  AKI in hospitalized children: comparing the pRIFLE, AKIN, and KDIGO definitions.

Authors:  Scott M Sutherland; John J Byrnes; Manish Kothari; Christopher A Longhurst; Sanjeev Dutta; Pablo Garcia; Stuart L Goldstein
Journal:  Clin J Am Soc Nephrol       Date:  2015-02-03       Impact factor: 8.237

2.  Risk of intravenous contrast material-mediated acute kidney injury: a propensity score-matched study stratified by baseline-estimated glomerular filtration rate.

Authors:  Jennifer S McDonald; Robert J McDonald; Rickey E Carter; Richard W Katzberg; David F Kallmes; Eric E Williamson
Journal:  Radiology       Date:  2014-01-16       Impact factor: 11.105

3.  Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality.

Authors:  P A McCullough; R Wolyn; L L Rocher; R N Levin; W W O'Neill
Journal:  Am J Med       Date:  1997-11       Impact factor: 4.965

4.  Incidence of nonconfounded post-computed tomography acute kidney injury in hospitalized patients with stable renal function receiving intravenous iodinated contrast material.

Authors:  Andreea Moore; Elliot Dickerson; Jonathan R Dillman; Dharshan Vummidi; David B Kershaw; Shokoufeh Khalatbari; Matthew S Davenport
Journal:  Curr Probl Diagn Radiol       Date:  2014-06-06

5.  Patterns of intravenous contrast material use and corticosteroid premedication in children--a survey of Society of Chairs of Radiology in Children's Hospitals (SCORCH) member institutions.

Authors:  Andrew T Trout; Jonathan R Dillman; James H Ellis; Richard H Cohan; Peter J Strouse
Journal:  Pediatr Radiol       Date:  2011-05-19

6.  Hospital-acquired renal insufficiency.

Authors:  Kevin Nash; Abdul Hafeez; Susan Hou
Journal:  Am J Kidney Dis       Date:  2002-05       Impact factor: 8.860

Review 7.  Measurement and estimation of GFR in children and adolescents.

Authors:  George J Schwartz; Dana F Work
Journal:  Clin J Am Soc Nephrol       Date:  2009-10-09       Impact factor: 8.237

8.  Propensity Score Matching as a Substitute for Randomized Controlled Trials on Acute Kidney Injury After Contrast Media Administration: A Systematic Review.

Authors:  Ilona A Dekkers; Aart J van der Molen
Journal:  AJR Am J Roentgenol       Date:  2018-08-07       Impact factor: 3.959

9.  Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material.

Authors:  Matthew S Davenport; Shokoufeh Khalatbari; Jonathan R Dillman; Richard H Cohan; Elaine M Caoili; James H Ellis
Journal:  Radiology       Date:  2013-01-29       Impact factor: 11.105

10.  The RIFLE and AKIN classifications for acute kidney injury: a critical and comprehensive review.

Authors:  José António Lopes; Sofia Jorge
Journal:  Clin Kidney J       Date:  2012-01-01
View more
  7 in total

1.  Hospitalized Children with Stable Kidney Function Rarely Develop Contrast-induced Nephropathy.

Authors:  Harriet J Paltiel
Journal:  Radiology       Date:  2020-01-21       Impact factor: 11.105

2.  Risk of acute kidney injury after contrast-enhanced computerized tomography: a systematic review and meta-analysis of 21 propensity score-matched cohort studies.

Authors:  Mikal Obed; Maria Magdalena Gabriel; Eva Dumann; Clara Vollmer Barbosa; Karin Weißenborn; Bernhard Magnus Wilhelm Schmidt
Journal:  Eur Radiol       Date:  2022-06-21       Impact factor: 5.315

Review 3.  Safety considerations related to intravenous contrast agents in pediatric imaging.

Authors:  Safia H E Cheeney; Ezekiel Maloney; Ramesh S Iyer
Journal:  Pediatr Radiol       Date:  2022-08-09

4.  Comparison of diagnostic criteria for acute kidney injury in critically ill children: a multicenter cohort study.

Authors:  Yuxian Kuai; Min Li; Jiao Chen; Zhen Jiang; Zhenjiang Bai; Hui Huang; Lin Wei; Ning Liu; Xiaozhong Li; Guoping Lu; Yanhong Li
Journal:  Crit Care       Date:  2022-07-07       Impact factor: 19.334

5.  Contrast media exposure in the perioperative period confers no additional risk of acute kidney injury in infants and young children undergoing cardiac surgery with cardiopulmonary bypass.

Authors:  Shengwen Guo; Liting Bai; Yuanyuan Tong; Jin Yu; Peiyao Zhang; Xin Duan; Jinping Liu
Journal:  Pediatr Nephrol       Date:  2021-02-07       Impact factor: 3.714

6.  A systematic review of the incidence of hypersensitivity reactions and post-contrast acute kidney injury after ioversol in more than 57,000 patients: part 1-intravenous administration.

Authors:  Aart J van der Molen; Ilona A Dekkers; Ibrahim Bedioune; Elisabeth Darmon-Kern
Journal:  Eur Radiol       Date:  2022-03-21       Impact factor: 7.034

Review 7.  Contrast-Associated Acute Kidney Injury: Advances and Challenges.

Authors:  Qingqing Li; Shengqi Pan
Journal:  Int J Gen Med       Date:  2022-02-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.